Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Rezum First in Man Feasibility Study for the Treatment of BPH With the Rezum System

NCT02940392 is registered in ClinicalTrials.gov with Boston Scientific Corporation as lead sponsor.

NCT NCT02940392
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02940392 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Rezum First in Man Feasibility Study for the Treatment of BPH With the Rezum System
Lead sponsor
Boston Scientific Corporation
Phase
Not applicable
Overall status
Completed
Start date
March 19, 2012
Completion date
May 19, 2017
Enrollment
15 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

adenoma, prostatic, benign prostatic hyperplasia, prostatic adenoma, prostatic hyperplasia, benign, prostatic hypertrophy, prostatic hypertrophy, benign, rezum